tazobactam has been researched along with Bacteroides Infections in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CH; Ho, MW; Hsueh, PR; Ko, WC; Lin, HH; Tseng, KH; Wu, PH | 1 |
| Chong, Y; Jeong, SH; Kim, M; Kim, WH; Lee, K; Lee, Y; Seo, YH; Yim, J; Yong, D | 1 |
| Armstrong, ES; Farrell, DJ; Palchak, M; Steenbergen, JN | 1 |
| Amancio Martins, W; Bahia, JL; Cara, DC; Coutinho, SC; DE Macedo Farias, L; Galuppo Diniz, C; Lopes DE Andrade, JP; Morais Apolonio, AC; Nicoli, JR; Roque DE Carvalho, MA; Valéria Dos Santos, K | 1 |
| Aldridge, KE | 2 |
| Duncanson, FP; Norden, CW; Talan, DA; Tan, JS; Wishnow, RM | 1 |
| Eliopoulos, GM; Moellering, RC; Pefanis, A; Thauvin-Eliopoulos, C | 1 |
1 review(s) available for tazobactam and Bacteroides Infections
| Article | Year |
|---|---|
Anaerobes in polymicrobial surgical infections: incidence, pathogenicity, and antimicrobial resistance.
Topics: Abdominal Abscess; Bacteremia; Bacteria, Anaerobic; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; beta-Lactamase Inhibitors; beta-Lactamases; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Incidence; Penicillanic Acid; Peritonitis; Piperacillin; Surgical Wound Infection; Tazobactam; Virulence | 1994 |
2 trial(s) available for tazobactam and Bacteroides Infections
| Article | Year |
|---|---|
In Vitro Activity of Ceftolozane-Tazobactam against Anaerobic Organisms Identified during the ASPECT-cIAI Study.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteroides; Bacteroides fragilis; Bacteroides Infections; Cephalosporins; Drug Therapy, Combination; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intraabdominal Infections; Metronidazole; Microbial Sensitivity Tests; Penicillanic Acid; Tazobactam | 2016 |
Treatment of hospitalized patients with complicated skin and skin structure infections: double-blind, randomized, multicenter study of piperacillin-tazobactam versus ticarcillin-clavulanate. The Piperacillin/Tazobactam Skin and Skin Structure Study Group.
Topics: Bacteroides Infections; Clavulanic Acids; Double-Blind Method; Drug Therapy, Combination; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Staphylococcus aureus; Tazobactam; Ticarcillin | 1993 |
5 other study(ies) available for tazobactam and Bacteroides Infections
| Article | Year |
|---|---|
Geographic patterns of antimicrobial susceptibilities for Bacteroides spp. worldwide: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme, 2007-2020.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteroides fragilis; Bacteroides Infections; Cefoxitin; Clindamycin; Humans; Leadership; Meropenem; Microbial Sensitivity Tests; Piperacillin; Tazobactam; Tigecycline | 2023 |
Antimicrobial susceptibility of clinical isolates of Bacteroides fragilis group organisms recovered from 2009 to 2012 in a Korean hospital.
Topics: Anti-Infective Agents; Bacteroides fragilis; Bacteroides Infections; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Inhibitory Concentration 50; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Republic of Korea; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tazobactam; Tertiary Care Centers; Thienamycins | 2015 |
In vitro selection of ertapenem and piperacillin/tazobactam-resistant strains of Bacteroides fragilis and analysis of their virulence in gnotobiotic mice.
Topics: Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; beta-Lactam Resistance; beta-Lactams; Ertapenem; Germ-Free Life; In Vitro Techniques; Mice; Microbial Sensitivity Tests; Penicillanic Acid; Phenotype; Piperacillin; Tazobactam; Virulence | 2010 |
Cross-resistance to beta-lactam-beta-lactamase inhibitor combinations and clindamycin among cefoxitin-resistant and cefoxitin-susceptible strains of the Bacteroides fragilis group.
Topics: Anti-Bacterial Agents; Bacteroides; Bacteroides fragilis; Bacteroides Infections; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Clindamycin; Drug Resistance, Microbial; Drug Synergism; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Tazobactam | 1993 |
Efficacy of ceftriaxone plus tazobactam in a rat model of intraabdominal abscess due to Bacteroides fragilis.
Topics: Abdomen; Abscess; Animals; Bacteroides fragilis; Bacteroides Infections; Ceftriaxone; Disease Models, Animal; Drug Therapy, Combination; Male; Penicillanic Acid; Peritoneal Diseases; Rats; Rats, Sprague-Dawley; Tazobactam | 1993 |